Resource Details

Menu

Current Topics in Pre-exposure Prophylaxis (PrEP)

Resource Topic: Clinical Issues, Emerging Issues, Special and Vulnerable Populations

Year Developed: 2016

Resource Type: Archived Webinar

Primary Audience: Clinicians Outreach Staff PCAs
Secondary Audience: C-Suite (CEOs, CFOs, CIOs, COOs, CMOs, etc)

Language: English

Developed by: The National LGBT Health Education Center at The Fenway Institute (See other resources developed by this organization.)

Resource Summary: Pre-exposure prophylaxis, or PrEP, is a pill taken once daily to help prevent HIV infection in uninfected people. In this webinar, Kevin Ard, MD, MPH will share updates on clinical approaches to managing patients on PrEP based on cutting-edge research data. Dr. Ard will also address common questions about the management of PrEP among HIV negative patients.

Resource Details: In this webinar, Kevin Ard, MD, MPH will share updates on clinical approaches to managing patients on PrEP based on cutting-edge research data. Dr. Ard will also address common questions about the management of PrEP among HIV negative patients. This webinar is supported by funding from Gilead Sciences, Inc.

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,375,000 with 0 percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.